Company Filing History:
1 out of 3,222 
1 out of 21 Years Active: 2023
Title: Powai Yuen - Innovator in Immunotherapy
Introduction
Powai Yuen is a notable inventor based in Beijing, CN, known for his contributions to the field of immunotherapy. With one patented invention under his name, Yuen is actively involved in the research and development of compounds that have significant implications for cancer treatment and immunological health.
Latest Patents
Yuen's primary patent is focused on TDO2 and IDO1 inhibitors. The patent describes pharmaceutical compositions aimed at modulating the activity of tryptophan 2,3-dioxygenase and indoleamine 2,3-dioxygenase 1. These inhibitors play a critical role in treating immunosuppression and conditions that can benefit from the inhibition of tryptophan degradation. Furthermore, this invention enhances the effectiveness of anti-cancer treatments by administering anti-cancer agents and addresses tumor-specific immunosuppression associated with cancer.
Career Highlights
Powai Yuen has garnered experience at several prestigious institutions. He has worked with well-known companies such as Genentech, Inc. and NewLink Genetics Corporation. His tenure at these organizations has facilitated advancements in his research and the successful development of innovative therapeutic solutions.
Collaborations
Throughout his career, Yuen has collaborated with notable professionals in his field, including Zhonghua Pei and Brendan Parr. These collaborations have contributed to the successful realization of his inventions and have fostered a dynamic environment for innovation in immunotherapy.
Conclusion
With his groundbreaking patent on TDO2 and IDO1 inhibitors, Powai Yuen is making significant strides in the treatment of cancer and immune-related conditions. His work exemplifies the positive impact of innovation in medicine, demonstrating a commitment to enhancing therapeutic efficacy and improving patient outcomes.